You are here: Home » International » News » Others
Business Standard

Pfizer vaccine 75% effective after first shot: Israeli study

A team of Israeli researchers showed that Covid-19 infections reduced by 75 per cent after the administration of the first dose of the Pfizer vaccine

Topics
Coronavirus Vaccine | Coronavirus Tests

IANS  |  Jerusalem 

Pfizer vaccine
Pfizer vaccine

A team of Israeli researchers on Friday showed that Covid-19 infections reduced by 75 per cent after the administration of the first dose of the Pfizer vaccine.

The data, published in the peer-reviewed Lancet medical journal, centered on a study of around 9,000 Sheba healthcare workers, around 7,000 of which received their first dose in January.

The researchers at Sheba Medical Center found a 75 per cent decrease in all infections and an 85 per cent reduction in symptomatic infections between 15-28 days after vaccination, The Jerusalem Post reported.

According to Gili Regev-Yochay, director of the hospital's Infectious Disease Epidemiology Unit, only 170 people became infected during the two week period. Of those who contracted the virus, 99 showed symptoms. Eighty-nine of the sick were unvaccinated.

She said the hospital is now completing research on the impact of the second dose, which she said researchers still believe is essential. However, she noted that the research supports the UK government's decision to spread out the time between the first and second shots of the vaccine in order to inoculate more people.

Regev-Yochay noted that there was at least one limitation on the data -- that hospital workers tend to be under the age of 65 and healthier than the rest of the population, so it is possible that less people got sick or showed symptoms for that reason.

--IANS

vc/arm

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, February 19 2021. 18:49 IST
RECOMMENDED FOR YOU